- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05253313
Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial (MAGIPAC)
Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery
Pancreatic cancer has the most dismal prognosis with a 5-year survival of 8%. The only curative treatment is surgery which is accompanied by great morbidity and mortality. Recent research indicates that Magnetic Resonance Imaging (MRI) is superior in detecting liver metastases compared with today's gold standard computed tomography (CT), which usually is a contraindication to surgery.
Investigators want to randomize patients with pancreatic cancer, who are eligible for surgery to a pre-operative MRI. The investigators want to examine if MRI is as good for the staging as CT and if MRI is better for the identification of liver metastases. Patients will have a follow-up period of 1 year to see if MRI changes the overall survival.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Currently, CT is the state of art for assessing and staging pancreatic cancer. However, it has its limitations when it comes to detecting small liver metastases, which are often found in pancreatic cancer. Recent research indicates that MRI is superior to CT when it comes to the detection of liver metastases. Thus, the investigators want to examine MRI's role in the assessment of pancreatic cancer.
The investigators want to conduct a nationwide RCT to examine the feasibility of using MRI for tumor staging and identification. The overall aim is to improve the selection of patients going to surgery so futile resections are avoided and increase the overall survival. Patients who are deemed eligible for pancreatic resection after being reviewed at a local multidisciplinary tumor board will be, upon consent, electronically randomized to one of two treatment arms (each arm will contain 100 patients). Patients within the control arm will as per usual proceed to surgery, whereas patients in the intervention arm will receive a pre-operative MRI scan. The MRI will be read by experienced gastroenterology radiologists who are blinded to the patient's identity and the initial CT findings. Treatment will be based on MRI findings. There will be a follow-up period of 1 year to see if MRI changes the overall survival. Within this RCT we will conduct three studies.
Study 1) The investigators want to compare pancreatic tumor staging with MRI versus standard upper abdominal CT, we hypothesize that MRI is not inferior to CT.
Study 2) The investigators want to assess MRI's ability to detect liver metastases vs standard upper abdominal CT, in patients otherwise deemed eligible for surgery. We hypothesize that MRI is superior to CT in the detection of liver metastases.
Study 3) The investigators want to assess the impact of MRI, thus patients will be followed for 1 year. We want to see if MRI changes the overall survival, treatment allocation, and recurrence.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Christian Flindt Nielsen., Cand. med.
- Telefonnummer: +4551530041
- E-mail: Cflindtn@gmail.com
Undersøgelse Kontakt Backup
- Navn: Jakob Kirkegaard, PhD
- Telefonnummer: +4522900604
- E-mail: jakob.kirkegaard@auh.rm.dk
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Must be eligible for curative pancreatic resection based on CT
- Must accept randomization
Exclusion Criteria:
- Not eligible for curative pancreatic resection
- Unable to undergo MRI.
- Did not accept randomization.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Ingen indgriben: Conventional
Patients who are eligible for surgery are randomized to MRI scan or standard curative surgery.
Patients in this arm will receive standard care according to danish standards without pre-operative MRI scans.
|
|
Andet: MRI scan
This arm includes patients who have been randomized to pre-operative MRI scans.
|
Patients will be randomized to a pre-operative scan or not.
The MRI scan will evaluate the local extent of the tumor and especially focus on identifying possible liver metastases unseen on the CT-scan.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Correlation in tumor staging (T- and N-stage) between CT and MR
Tidsramme: 1 year
|
The degree of correlation between CT and MR with respect to T- and N-stage.
Will be assessed using Kappa-values.
|
1 year
|
Proportion of patients with liver metastases in the intervention arm
Tidsramme: 1 year
|
To examine if MRI scans identify more metastases than conventional CT scans.
Measured by the Chi2-test.
|
1 year
|
One-year survival after randomization
Tidsramme: 1 year
|
To examine if MRI scans improves survival of patients with pancreatic cancer.
|
1 year
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Frank Viborg Mortensen, Prof., Professor MTK AUh
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 22552255
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med MRI scan
-
The Hospital for Sick ChildrenUniversity Health Network, TorontoAfsluttet
-
Centre Antoine LacassagneRekrutteringDiffust storcellet B-celle lymfomFrankrig
-
Stanford UniversityAfsluttetDiagnostisk billeddannelse | Kræftdiagnose | Diagnostiske teknikker og procedurerForenede Stater
-
Check-Cap Ltd.AfsluttetRisiko for tyktarmskræftIsrael
-
Seoul National University Bundang HospitalBayerAfsluttetTraumaKorea, Republikken
-
Medical University of ViennaAfsluttet
-
Cambridge University Hospitals NHS Foundation TrustRekrutteringBrystkræftDet Forenede Kongerige
-
The Hospital for Sick ChildrenTilmelding efter invitation
-
University Hospital AugsburgRekrutteringNeoplasmer | Neoplasma Metastase | Metastatisk kræftTyskland
-
Mayo ClinicNational Cancer Institute (NCI)RekrutteringProstata karcinom | Fase I prostatakræft AJCC v8 | Fase II prostatakræft AJCC v8Forenede Stater